CCG-232601
Code | Size | Price |
---|
TAR-T26967-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26967-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T26967-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
CCG-232601 is a inhibitor of the Rho/MRTF/SRF transcriptional pathway.
CAS:
1922099-21-5
Formula:
C24H20ClF2N3O2
Molecular Weight:
455.89
Purity:
0.98
SMILES:
FC1(F)CC(CN(C1)C(=O)c1cccc(c1)-c1ccncc1)C(=O)Nc1ccc(Cl)cc1
References
1. Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma In Press, Corrected Proof, Available online 10 March 2017 Kim M. Hutchings, Erika M. Lisabeth, Walajapet Rajeswaran, Michael W. Wilson, Roderick J. Sorenson, Phillip L. Campbell, Jeffrey H. Ruth, Asif Amin, Pei-Suen Tsou, Jeffrey R. Leipprandt, Samuel R. Olson, Bo Wen, Ting Zhao, Duxin Sun, Dinesh Khanna, David A. Fox, Richard R. Neubig, Scott D. Larsen